Aurobindo Pharma’s arm restarts Penicillin-G manufacturing facility in AP

30 Jun 2025 Evaluate

Aurobindo Pharma’s wholly owned stepdown subsidiary -- Lyfius Pharma has re-started the production at its Penicillin-G manufacturing facility, at Kakinada, Andhra Pradesh (AP), with immediate effect, after receiving the consent to operate (CTO) from Andhra Pradesh from Andhra Pradesh Pollution Control Board (APPCB), on June 29, 2025.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1192.90 11.70 (0.99%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×